Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [09/02/2025 06:09 PDT] AEMD Expected to Trade Up After Bullish Patterns Develop
• [08/22/2025 21:21 PDT] Market Maker Surveillance Report. AEMD, Losing Stocks With Lowest Price Friction For Friday, August 22nd 2025
• [08/22/2025 08:16 PDT] Aethlon Medical, Inc. (NASDAQ:AEMD), Up By 100% ($2.19) From $2.19 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [08/21/2025 21:21 PDT] Market Maker Surveillance Report. AEMD, Bullishly Biased Price Friction For Thursday, August 21st 2025
• [08/21/2025 10:29 PDT] Aethlon Medical, Inc. (NASDAQ:AEMD), Up By 100% ($1.2) From $1.2 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [08/06/2025 07:28 PDT] AEMD Expected to Trade Up After Bullish Patterns Develop
• [07/21/2025 07:11 PDT] AEMD Expected to Trade Up After Bullish Patterns Develop